Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 13/20 | 0.57 |
| ▸ | ERBB2 | P04626 | 4/20 | 0.57 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.53 |
| ▸ | SRC | P12931 | 6/20 | 0.51 |
| ▸ | KDR | P35968 | 3/20 | 0.51 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL4039319 | 0.93 | EGFR (0.53) | EGFRERBB2KCNH2SRCKDR | |
| SCHEMBL4031239 | 0.88 | EGFR (0.71) | EGFRERBB2KCNH2SRCKDR | |
| Hydrochloric Acid SCHEMBL4034029 | 0.87 | EGFR (0.70) | EGFRERBB2KCNH2SRCKDR | |
| SCHEMBL4036988 | 0.85 | EGFR (0.56) | EGFRERBB2KCNH2SRCKDR | |
| SCHEMBL4046007 | 0.84 | EGFR (0.59) | EGFRERBB2KCNH2SRCKDR | |
| Trifluoroacetic Acid SCHEMBL4032839 | 0.83 | EGFR (0.58) | EGFRERBB2KCNH2SRCKDR | |
| Trifluoroacetic Acid SCHEMBL4034846 | 0.83 | EGFR (0.52) | EGFRERBB2KCNH2SRCKDR | |
| SCHEMBL4039322 | 0.83 | EGFR (0.56) | EGFRERBB2KCNH2SRCKDR | |
| SCHEMBL4033491 | 0.83 | EGFR (0.79) | EGFRERBB2KCNH2SRC | |
| SCHEMBL5406753 | 0.80 | EGFR (0.73) | EGFRERBB2KCNH2SRCKDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1444211-B1 | QUINAZOLINE DERIVATIVES AS ANTITUMOR AGENTS | ASTRAZENECA AB (SE) | 2009-01-21 | — | — | EP | disclosed |